RECURRENT ADULT HODGKIN LYMPHOMA
Clinical trials for RECURRENT ADULT HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADULT HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy takes on HIV and cancer in one shot
Disease control OngoingThis early-phase trial tests a gene therapy approach for people with HIV who also have lymphoma that has returned or not responded to treatment. Researchers take the patient's own stem cells, add anti-HIV genes in the lab, and return them after a stem cell transplant. The goal is…
Matched conditions: RECURRENT ADULT HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Matched conditions: RECURRENT ADULT HODGKIN LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC